Scalable Purification of Adeno-associated Virus Serotype 1 (AAV1) and AAV8 Vectors, Using Dual Ion-Exchange Adsorptive Membranes
- 1 September 2009
- journal article
- research article
- Published by SAGE Publications in Human Gene Therapy
- Vol. 20 (9) , 1013-1021
Abstract
In vivo gene transduction with adeno-associated virus (AAV)-based vectors depends on laborious procedures for the production of high-titer vector stocks. Purification steps for efficient clearance of impurities such as host cell proteins and empty vector particles are required to meet end-product specifications. Therefore, the development of alternative, realistic methods to facilitate a scalable virus recovery procedure is critical to promote in vivo investigations. However, the conventional purification procedure with resin-based packed-bed chromatography suffers from a number of limitations, including variations in pressure, slow pore diffusion, and large bed volumes. Here we have employed disposable high-performance anion- and cation-exchange membrane adsorbers to effectively purify recombinant viruses. As a result of isoelectric focusing analysis, the isoelectric point of empty particles was found to be significantly higher than that of packaged virions. Therefore, AAV vector purification with the membrane adsorbers was successful and allowed higher levels of gene transfer in vivo without remarkable signs of toxicity or inflammation. Electron microscopy of the AAV vector stocks obtained revealed highly purified virions with as few as 0.8% empty particles. Furthermore, the membrane adsorbers enabled recovery of AAV vectors in the transduced culture supernatant. Also, the ion-exchange enrichment of retroviral vectors bearing the amphotropic envelope was successful. This rapid and scalable viral purification protocol using disposable membrane adsorbers is particularly promising for in vivo experimentation and clinical investigations.Keywords
This publication has 16 references indexed in Scilit:
- Purification of adenovirus and adeno-associated virus: comparison of novel membrane-based technology to conventional techniquesGene Therapy, 2005
- Current issues in adeno-associated viral vector productionGene Therapy, 2005
- Large-Scale Production of Recombinant Viruses by Use of a Large Culture Vessel with Active GassingHuman Gene Therapy, 2005
- In situ generation of pseudotyped retroviral progeny by adenovirus‐mediated transduction of tumor cells enhances the killing effect of HSV‐tk suicide gene therapy in vitro and in vivoThe Journal of Gene Medicine, 2004
- Scalable Purification of Adeno-Associated Virus Type 2, 4, or 5 Using Ion-Exchange ChromatographyHuman Gene Therapy, 2002
- [22] Adeno-associated viral vector-mediated gene therapy of ischemia-induced neuronal death2002
- Membrane ion-exchange chromatography for process-scale antibody purificationJournal of Chromatography A, 2001
- Purification of Recombinant Adeno-Associated Virus Vectors by Column Chromatography and Its Performance in VivoHuman Gene Therapy, 2000
- Efficient Serum-Free Retroviral Gene Transfer into Primitive Human Hematopoietic Progenitor Cells by a Defined, High-Titer, Nonconcentrated Vector-Containing MediumHuman Gene Therapy, 1998
- A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.Proceedings of the National Academy of Sciences, 1996